Skip to main content

Venous Thromboembolism Risk Assessment and Prophylaxis Use in Pediatric, Adolescent, and Young Adult Hematology Oncology Patients.

Publication ,  Journal Article
Bell, AD; Hockenberry, M; Landier, W; Ewing, N
Published in: Journal of pediatric hematology/oncology
August 2015

No widely accepted method exists to evaluate pediatric hematology oncology patients for the risk of venous thromboembolism (VTE) and the need for prophylaxis. The use of a VTE risk-assessment tool and standardized guidelines for prophylaxis could increase the use of appropriate prophylaxis and reduce the number of VTEs in patients, thereby decreasing morbidity, mortality, hospitalization, and cost. The purpose of this project was to implement and assess the compliance of a pediatric-specific VTE risk-assessment tool in hospitalized pediatric, adolescent, and young adult hematology oncology patients. From the 114 pediatric, adolescent, and young adult patients requiring assessment, 91 (80%) VTE assessments were completed and 87 (96%) were completed accurately. Eighty percent of the at-risk patients were ordered VTE prophylaxis. The use of a VTE risk-assessment tool in pediatric hematology oncology patients is a feasible way to assess patients for their risk of developing a VTE.

Duke Scholars

Published In

Journal of pediatric hematology/oncology

DOI

EISSN

1536-3678

ISSN

1077-4114

Publication Date

August 2015

Volume

37

Issue

6

Start / End Page

455 / 458

Related Subject Headings

  • Young Adult
  • Venous Thromboembolism
  • Survival Rate
  • Risk Assessment
  • Retrospective Studies
  • Prognosis
  • Oncology & Carcinogenesis
  • Male
  • Infant, Newborn
  • Infant
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bell, A. D., Hockenberry, M., Landier, W., & Ewing, N. (2015). Venous Thromboembolism Risk Assessment and Prophylaxis Use in Pediatric, Adolescent, and Young Adult Hematology Oncology Patients. Journal of Pediatric Hematology/Oncology, 37(6), 455–458. https://doi.org/10.1097/mph.0000000000000384
Bell, Alison D., Marilyn Hockenberry, Wendy Landier, and Nadia Ewing. “Venous Thromboembolism Risk Assessment and Prophylaxis Use in Pediatric, Adolescent, and Young Adult Hematology Oncology Patients.Journal of Pediatric Hematology/Oncology 37, no. 6 (August 2015): 455–58. https://doi.org/10.1097/mph.0000000000000384.
Bell AD, Hockenberry M, Landier W, Ewing N. Venous Thromboembolism Risk Assessment and Prophylaxis Use in Pediatric, Adolescent, and Young Adult Hematology Oncology Patients. Journal of pediatric hematology/oncology. 2015 Aug;37(6):455–8.
Bell, Alison D., et al. “Venous Thromboembolism Risk Assessment and Prophylaxis Use in Pediatric, Adolescent, and Young Adult Hematology Oncology Patients.Journal of Pediatric Hematology/Oncology, vol. 37, no. 6, Aug. 2015, pp. 455–58. Epmc, doi:10.1097/mph.0000000000000384.
Bell AD, Hockenberry M, Landier W, Ewing N. Venous Thromboembolism Risk Assessment and Prophylaxis Use in Pediatric, Adolescent, and Young Adult Hematology Oncology Patients. Journal of pediatric hematology/oncology. 2015 Aug;37(6):455–458.

Published In

Journal of pediatric hematology/oncology

DOI

EISSN

1536-3678

ISSN

1077-4114

Publication Date

August 2015

Volume

37

Issue

6

Start / End Page

455 / 458

Related Subject Headings

  • Young Adult
  • Venous Thromboembolism
  • Survival Rate
  • Risk Assessment
  • Retrospective Studies
  • Prognosis
  • Oncology & Carcinogenesis
  • Male
  • Infant, Newborn
  • Infant